LAVA Therapeutics NV (LVTX)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current LVTX market cap is 34.85M. The company's latest EPS is USD -0.9547 and P/E is -1.38.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 353k | 6.99M | 0 | 0 | 0 |
| Operating Income | -15.89M | -1.95M | -9.36M | -11.28M | -7.59M |
| Net Income | -6.5M | -553k | -8.3M | -12.3M | -3.48M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.5M | 5.35M | 19.39M | 6.77M | 11.98M |
| Operating Income | -14.92M | -43.61M | -34.84M | -43.39M | -29.69M |
| Net Income | -15.51M | -42.36M | -31.91M | -41.87M | -25.11M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 101.71M | 99.08M | 92.28M | 83.36M | 71.16M |
| Total Liabilities | 50.53M | 48.41M | 49.41M | 50.36M | 45.37M |
| Total Equity | 51.18M | 50.67M | 42.88M | 32.99M | 25.78M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 20.49M | 139.25M | 143.43M | 101.67M | 80.83M |
| Total Liabilities | 12.87M | 20.88M | 57.39M | 50.31M | 53.09M |
| Total Equity | 7.62M | 118.37M | 86.04M | 51.36M | 27.75M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -38.97M | -1.13M | -9.51M | -18.14M | -11.65M |
| Investing | -17.64M | 718k | 1.06M | 1.5M | 15.16M |
| Financing | -571k | N/A | 5k | -363k | N/A |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.31M | -28.65M | 4.04M | -40.28M | -19.54M |
| Investing | -502k | -43.55M | 9.35M | -17.64M | 12.48M |
| Financing | 18.97M | 151.16M | 283k | N/A | -569k |
| Market Cap | 34.85M |
| Price to Earnings Ratio | -1.38 |
| Price to Sales Ratio | 2.9 |
| Price to Cash Ratio | 0.99 |
| Price to Book Ratio | 1.25 |
| Dividend Yield | - |
| Shares Outstanding | 26.31M |
| Average Volume (1 week) | 11.54k |
| Average Volume (1 Month) | 36.94k |
| 52 Week Change | -28.76% |
| 52 Week High | 2.39 |
| 52 Week Low | 0.8502 |
| Spread (Intraday) | 0.15 (10.71%) |
| Company Name | LAVA Therapeutics NV |
| Address |
yalelaan 62 utrecht, utrecht 3584 CM |
| Website | https://www.lavatherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
